Published in Appl Health Econ Health Policy on August 01, 2014
Maintenance Dialysis throughout the World in Years 1990 and 2010. J Am Soc Nephrol (2015) 1.15
Economic impact of a modification of the treatment trajectories of patients with end-stage renal disease. Nephrol Dial Transplant (2015) 0.81
The economic considerations of patients and caregivers in choice of dialysis modality. Hemodial Int (2016) 0.81
Cost-Effectiveness Analysis of High-Efficiency Hemodiafiltration Versus Low-Flux Hemodialysis Based on the Canadian Arm of the CONTRAST Study. Appl Health Econ Health Policy (2015) 0.77
More Use of Peritoneal Dialysis Gives Significant Savings: A Systematic Review and Health Economic Decision Model. J Clin Med Res (2016) 0.75
Continuous ambulatory peritoneal dialysis: perspectives on patient selection in low- to middle-income countries. Int J Nephrol Renovasc Dis (2017) 0.75
In-center hemodialysis six times per week versus three times per week. N Engl J Med (2010) 10.73
An introduction to Markov modelling for economic evaluation. Pharmacoeconomics (1998) 4.27
The effects of frequent nocturnal home hemodialysis: the Frequent Hemodialysis Network Nocturnal Trial. Kidney Int (2011) 4.27
Patient ratings of dialysis care with peritoneal dialysis vs hemodialysis. JAMA (2004) 3.46
Broadening Options for Long-term Dialysis in the Elderly (BOLDE): differences in quality of life on peritoneal dialysis compared to haemodialysis for older patients. Nephrol Dial Transplant (2010) 2.67
Hemodialysis access usage patterns in the incident dialysis year and associated catheter-related complications. Am J Kidney Dis (2012) 2.52
The effect of contraindications and patient preference on dialysis modality selection in ESRD patients in The Netherlands. Am J Kidney Dis (2004) 2.40
The quality of life and cost utility of home nocturnal and conventional in-center hemodialysis. Kidney Int (2003) 2.18
Estimating the financial cost of chronic kidney disease to the NHS in England. Nephrol Dial Transplant (2012) 1.83
Associations of dialysis modality and infectious mortality in incident dialysis patients in Australia and New Zealand. Am J Kidney Dis (2008) 1.69
Comparing mortality of peritoneal and hemodialysis patients in the first 2 years of dialysis therapy: a marginal structural model analysis. Clin J Am Soc Nephrol (2013) 1.63
Preference-based quality of life of patients on renal replacement therapy: a systematic review and meta-analysis. Value Health (2008) 1.55
Hemodialysis and peritoneal dialysis: patients' assessment of their satisfaction with therapy and the impact of the therapy on their lives. Clin J Am Soc Nephrol (2006) 1.54
The cost-effectiveness of increasing kidney transplantation and home-based dialysis. Nephrology (Carlton) (2009) 1.48
Cost-effectiveness analysis of renal replacement therapy in Austria. Nephrol Dial Transplant (2011) 1.38
Systematic review of the effectiveness and cost-effectiveness, and economic evaluation, of home versus hospital or satellite unit haemodialysis for people with end-stage renal failure. Health Technol Assess (2003) 1.35
Why patients with ESRD do not select self-care dialysis as a treatment option. Am J Kidney Dis (2003) 1.32
Hospital utilization among chronic dialysis patients. J Am Soc Nephrol (2000) 1.19
Economic evaluation of end stage renal disease treatment. Health Policy (1998) 1.18
Peritoneal dialysis versus hemodialysis: risks, benefits, and access issues. Adv Chronic Kidney Dis (2011) 1.13
An update on the comparisons of mortality outcomes of hemodialysis and peritoneal dialysis patients. Semin Nephrol (2011) 1.07
Burden of chronic kidney disease: an international perspective. Adv Chronic Kidney Dis (2010) 1.07
UK Renal Registry 13th Annual Report (December 2010): Chapter 2: UK RRT prevalence in 2009: national and centre-specific analyses. Nephron Clin Pract (2011) 1.00
Association of dialysis modality with risk for infection-related hospitalization: a propensity score-matched cohort analysis. Clin J Am Soc Nephrol (2012) 1.00
Gaining efficiencies: resources and demand for dialysis around the globe. Value Health (2008) 0.99
Hemodialysis for end-stage renal disease: a cost-effectiveness analysis of treatment-options. Int J Technol Assess Health Care (2005) 0.98
Cost-effectiveness analysis of the Spanish renal replacement therapy program. Perit Dial Int (2011) 0.94
UK Renal Registry 13th Annual Report (December 2010): Chapter 1: UK RRT incidence in 2009: national and centre-specific analyses. Nephron Clin Pract (2011) 0.94
UK Renal Registry 16th annual report: chapter 1 UK renal replacement therapy incidence in 2012: national and centre-specific analyses. Nephron Clin Pract (2014) 0.90
UK Renal Registry 16th annual report: chapter 2 UK RRT prevalence in 2012: national and centre-specific analyses. Nephron Clin Pract (2014) 0.89
Dialysis for end-stage renal disease. Determining a cost-effective approach. Int J Technol Assess Health Care (2001) 0.88
The role of peritoneal dialysis in modern renal replacement therapy. Postgrad Med J (2013) 0.83
Trends in renal replacement therapy and changes in peritoneal dialysis utilization in the United kingdom. Perit Dial Int (2011) 0.82
The impact of home nocturnal hemodialysis on end-stage renal disease therapies: a decision analysis. Kidney Int (2006) 0.81
UK Renal Registry 16th annual report: chapter 10 haemoglobin, ferritin and erythropoietin amongst UK adult dialysis patients in 2012: national and centre-specific analyses. Nephron Clin Pract (2014) 0.80
Back to the future: changes in the dialysis delivery model in the UK. Perit Dial Int (2011) 0.77
Bloodstream infections associated with parenteral nutrition preparation methods in the United States: a retrospective, large database analysis. JPEN J Parenter Enteral Nutr (2011) 1.61
Nutrition therapy cost analysis in the US: pre-mixed multi-chamber bag vs compounded parenteral nutrition. Appl Health Econ Health Policy (2011) 1.04
Economic evaluation of BST-CarGel as an adjunct to microfracture vs microfracture alone in knee cartilage surgery. J Med Econ (2014) 0.84
The financial impact of increasing home-based high dose haemodialysis and peritoneal dialysis. BMC Nephrol (2014) 0.81
High-dose hemodialysis versus conventional in-center hemodialysis: a cost-utility analysis from a UK payer perspective. Value Health (2015) 0.78
Bloodstream infections in patients receiving manufactured parenteral nutrition with vs without lipids: is the use of lipids really deleterious? JPEN J Parenter Enteral Nutr (2011) 0.77
Parenteral nutrition prescribing pattern: a medical chart review of 191 preterm infants. Nutr Clin Pract (2013) 0.75